title: Establishment registration and listing for manufacturers of human cellular and tissue-based products--FDA. Proposed rule; reopening of comment period.
abstract: The Food and Drug Administration (FDA) is reopening the comment period for the proposed rule concerning establishment registration and listing for manufacturers of human cellular and tissue-based products that was published in the Federal Register of May 14, 1998 (63 FR 26744). FDA is taking this action in response to a request for an extension and to allow interested parties additional time for review and to submit comments.
mesh_terms: D017690:Cell Transplantation / Q000592:standards*; D003140:Communicable Disease Control; D003257:Consumer Product Safety / Q000331:legislation & jurisprudence*; D006801:Humans; D007221:Industry / Q000331:legislation & jurisprudence* / Q000592:standards; D011786:Quality Control; D014183:Transplantation, Heterologous / Q000592:standards*; D014184:Transplantation, Homologous / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration